Global Sustained Release Injectables Industry Research Report 2020, Forecast to 2025

August 2020 | 109 pages | ID: G178482FABCEEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Sustained Release Injectables market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Sustained Release Injectables is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Sustained Release Injectables industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Sustained Release Injectables by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Sustained Release Injectables market are discussed.

The market is segmented by types:

• Naltrexone
• Exenatide
• Estradiol
• Other

It can be also divided by applications:

• Diabetes
• Leukemia
• Acromegaly
• Other

And this report covers the historical situation, present status and the future prospects of the global Sustained Release Injectables market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• AstraZeneca
• Biomarin
• Roche
• Eli Lilly
• Avadel
• Sanofi
• Critical Pharmaceuticals
• Aurobindo
• Novartis
• Camurus
• Alkermes
• Taiwan Liposome Company
• Amylin
• Ascendis Pharma

Report Includes:

• xx data tables and xx additional tables
• An overview of global Sustained Release Injectables market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Sustained Release Injectables market
• Profiles of major players in the industry, including AstraZeneca, Biomarin, Roche, Eli Lilly, Avadel.....

Research Objectives

• To study and analyze the global Sustained Release Injectables consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Sustained Release Injectables market by identifying its various subsegments.
• Focuses on the key global Sustained Release Injectables manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Sustained Release Injectables with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Sustained Release Injectables submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Sustained Release Injectables Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Sustained Release Injectables Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 SUSTAINED RELEASE INJECTABLES INDUSTRY OVERVIEW

2.1 Global Sustained Release Injectables Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Sustained Release Injectables Global Import Market Analysis
  2.1.2 Sustained Release Injectables Global Export Market Analysis
  2.1.3 Sustained Release Injectables Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Naltrexone
  2.2.2 Exenatide
  2.2.3 Estradiol
  2.2.4 Other
2.3 Market Analysis by Application
  2.3.1 Diabetes
  2.3.2 Leukemia
  2.3.3 Acromegaly
  2.3.4 Other
2.4 Global Sustained Release Injectables Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Sustained Release Injectables Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Sustained Release Injectables Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Sustained Release Injectables Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Sustained Release Injectables Manufacturer Market Share
  2.4.5 Top 10 Sustained Release Injectables Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Sustained Release Injectables Market
  2.4.7 Key Manufacturers Sustained Release Injectables Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Sustained Release Injectables Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Sustained Release Injectables Industry Impact
  2.7.1 How the Covid-19 is Affecting the Sustained Release Injectables Industry
  2.7.2 Sustained Release Injectables Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Sustained Release Injectables Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Sustained Release Injectables Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Sustained Release Injectables Sales Market Share by Region
4.2 Global Sustained Release Injectables Revenue Market Share by Region (2015-2019)
4.3 Global Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Sustained Release Injectables Market Size Detail
  4.4.1 North America Sustained Release Injectables Sales Growth Rate (2015-2020)
  4.4.2 North America Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Sustained Release Injectables Market Size Detail
  4.5.1 Europe Sustained Release Injectables Sales Growth Rate (2015-2020)
  4.5.2 Europe Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Sustained Release Injectables Market Size Detail
  4.6.1 Japan Sustained Release Injectables Sales Growth Rate (2015-2020)
  4.6.2 Japan Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Sustained Release Injectables Market Size Detail
  4.7.1 China Sustained Release Injectables Sales Growth Rate (2015-2020)
  4.7.2 China Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SEGMENT BY TYPE

5.1 Global Sustained Release Injectables Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Sustained Release Injectables Sales and Market Share by Type (2015-2020)
  5.1.2 Global Sustained Release Injectables Revenue and Market Share by Type (2015-2020)
5.2 Naltrexone Sales Growth Rate and Price
  5.2.1 Global Naltrexone Sales Growth Rate (2015-2020)
  5.2.2 Global Naltrexone Price (2015-2020)
5.3 Exenatide Sales Growth Rate and Price
  5.3.1 Global Exenatide Sales Growth Rate (2015-2020)
  5.3.2 Global Exenatide Price (2015-2020)
5.4 Estradiol Sales Growth Rate and Price
  5.4.1 Global Estradiol Sales Growth Rate (2015-2020)
  5.4.2 Global Estradiol Price (2015-2020)
5.5 Other Sales Growth Rate and Price
  5.5.1 Global Other Sales Growth Rate (2015-2020)
  5.5.2 Global Other Price (2015-2020)

6 GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SEGMENT BY APPLICATION

6.1 Global Sustained Release InjectablesSales Market Share by Application (2015-2020)
6.2 Diabetes Sales Growth Rate (2015-2020)
6.3 Leukemia Sales Growth Rate (2015-2020)
6.4 Acromegaly Sales Growth Rate (2015-2020)
6.5 Other Sales Growth Rate (2015-2020)

7 GLOBAL SUSTAINED RELEASE INJECTABLES MARKET FORECAST

7.1 Global Sustained Release Injectables Sales, Revenue Forecast
  7.1.1 Global Sustained Release Injectables Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Sustained Release Injectables Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Sustained Release Injectables Price and Trend Forecast (2020-2025)
7.2 Global Sustained Release Injectables Sales Forecast by Region (2020-2025)
  7.2.1 North America Sustained Release Injectables Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Sustained Release Injectables Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Sustained Release Injectables Production, Revenue Forecast (2020-2025)
  7.2.4 China Sustained Release Injectables Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF SUSTAINED RELEASE INJECTABLES INDUSTRY KEY MANUFACTURERS

8.1 AstraZeneca
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 AstraZeneca Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 AstraZeneca News
8.2 Biomarin
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Biomarin Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Biomarin News
8.3 Roche
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Roche Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Roche News
8.4 Eli Lilly
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Eli Lilly Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Eli Lilly News
8.5 Avadel
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Avadel Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Avadel News
8.6 Sanofi
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Sanofi Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Sanofi News
8.7 Critical Pharmaceuticals
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Critical Pharmaceuticals Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Critical Pharmaceuticals News
8.8 Aurobindo
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Aurobindo Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Aurobindo News
8.9 Novartis
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Novartis Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Novartis News
8.10 Camurus
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Camurus Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Camurus News
8.11 Alkermes
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 Alkermes Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 Alkermes News
8.12 Taiwan Liposome Company
  8.12.1 Company Details
  8.12.2 Product Information
  8.12.3 Taiwan Liposome Company Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.12.4 Main Business Overview
  8.12.5 Taiwan Liposome Company News
8.13 Amylin
  8.13.1 Company Details
  8.13.2 Product Information
  8.13.3 Amylin Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.13.4 Main Business Overview
  8.13.5 Amylin News
8.14 Ascendis Pharma
  8.14.1 Company Details
  8.14.2 Product Information
  8.14.3 Ascendis Pharma Sustained Release Injectables Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.14.4 Main Business Overview
  8.14.5 Ascendis Pharma News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Sustained Release Injectables Picture
Figure Research Programs/Design for This Report
Figure Global Sustained Release Injectables Market by Regions (2019)
Table Global Market Sustained Release Injectables Comparison by Regions (M USD) 2019-2025
Table Global Sustained Release Injectables Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Sustained Release Injectables by Type in 2019
Figure Naltrexone Picture
Figure Exenatide Picture
Figure Estradiol Picture
Figure Other Picture
Table Global Sustained Release Injectables Sales by Application (2019-2025)
Figure Global Sustained Release Injectables Sales Market Share by Application in 2019
Figure Diabetes Picture
Figure Leukemia Picture
Figure Acromegaly Picture
Figure Other Picture
Table Global Sustained Release Injectables Sales by Manufacturer (2018-2020)
Figure Global Sustained Release Injectables Sales Market Share by Manufacturer in 2019
Table Global Sustained Release Injectables Revenue by Manufacturer (2018-2020)
Figure Global Sustained Release Injectables Revenue Market Share by Manufacturer in 2019
Table Global Sustained Release Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Sustained Release Injectables Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Sustained Release Injectables Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Sustained Release Injectables Market
Table Key Manufacturers Sustained Release Injectables Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sustained Release Injectables
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Sustained Release Injectables Sales (K Units) by Region (2015-2020)
Table Global Sustained Release Injectables Sales Market Share by Region (2015-2019)
Figure Global Sustained Release Injectables Sales Market Share by Region (2015-2019)
Figure Global Sustained Release Injectables Sales Market Share by Region in 2018
Table Global Sustained Release Injectables Revenue (Million US$) by Region (2015-2020)
Table Global Sustained Release Injectables Revenue Market Share by Region (2015-2020)
Figure Global Sustained Release Injectables Revenue Market Share by Region (2015-2020)
Figure Global Sustained Release Injectables Revenue Market Share by Region in 2019
Table Global Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Sustained Release Injectables Sales (K Units) Growth Rate (2015-2020)
Table North America Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Sustained Release Injectables Sales (K Units) Growth Rate (2015-2020)
Table Europe Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Sustained Release Injectables Sales (K Units) Growth Rate (2015-2020)
Table Japan Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Sustained Release Injectables Sales (K Units) Growth Rate (2015-2020)
Table China Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Sustained Release Injectables Sales by Type (2015-2020)
Table Global Sustained Release Injectables Sales Market Share by Type (2015-2020)
Figure Global Sustained Release Injectables Sales Market Share by Type in 2019
Table Global Sustained Release Injectables Revenue by Type (2015-2020)
Table Global Sustained Release Injectables Revenue Market Share by Type (2015-2020)
Figure Global Sustained Release Injectables Revenue Market Share by Type in 2019
Figure Global Naltrexone Sales Growth Rate (2015-2020)
Figure Global Naltrexone Price (2015-2020)
Figure Global Exenatide Sales Growth Rate (2015-2020)
Figure Global Exenatide Price (2015-2020)
Figure Global Estradiol Sales Growth Rate (2015-2020)
Figure Global Estradiol Price (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Sustained Release Injectables Sales by Application (2015-2020)
Table Global Sustained Release Injectables Sales Market Share by Application (2015-2020)
Figure Global Sustained Release Injectables Sales Market Share by Application in 2019
Figure Global Diabetes Sales Growth Rate (2015-2020)
Figure Global Leukemia Sales Growth Rate (2015-2020)
Figure Global Acromegaly Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Sustained Release Injectables Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Sustained Release Injectables Price and Trend Forecast (2020-2025)
Table Global Sustained Release Injectables Sales (K Units) Forecast by Region (2020-2025)
Figure Global Sustained Release Injectables Production Market Share Forecast by Region (2020-2025)
Figure North America Sustained Release Injectables Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Sustained Release Injectables Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Sustained Release Injectables Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Sustained Release Injectables Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table AstraZeneca Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of AstraZeneca
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Sustained Release Injectables Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Biomarin Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Biomarin
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biomarin Sustained Release Injectables Market Share (2018-2020)
Table Biomarin Main Business
Table Biomarin Recent Development
Table Roche Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Roche
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche Sustained Release Injectables Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table Eli Lilly Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Eli Lilly
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly Sustained Release Injectables Market Share (2018-2020)
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Avadel Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Avadel
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Avadel Sustained Release Injectables Market Share (2018-2020)
Table Avadel Main Business
Table Avadel Recent Development
Table Sanofi Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Sanofi
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi Sustained Release Injectables Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Critical Pharmaceuticals Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Critical Pharmaceuticals
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Critical Pharmaceuticals Sustained Release Injectables Market Share (2018-2020)
Table Critical Pharmaceuticals Main Business
Table Critical Pharmaceuticals Recent Development
Table Aurobindo Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Aurobindo
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Aurobindo Sustained Release Injectables Market Share (2018-2020)
Table Aurobindo Main Business
Table Aurobindo Recent Development
Table Novartis Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Novartis
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis Sustained Release Injectables Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Camurus Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Camurus
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Camurus Sustained Release Injectables Market Share (2018-2020)
Table Camurus Main Business
Table Camurus Recent Development
Table Alkermes Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Alkermes
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alkermes Sustained Release Injectables Market Share (2018-2020)
Table Alkermes Main Business
Table Alkermes Recent Development
Table Taiwan Liposome Company Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Taiwan Liposome Company
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Taiwan Liposome Company Sustained Release Injectables Market Share (2018-2020)
Table Taiwan Liposome Company Main Business
Table Taiwan Liposome Company Recent Development
Table Amylin Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Amylin
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Amylin Sustained Release Injectables Market Share (2018-2020)
Table Amylin Main Business
Table Amylin Recent Development
Table Ascendis Pharma Company Profile
Figure Sustained Release Injectables Product Picture and Specifications of Ascendis Pharma
Table Sustained Release Injectables Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ascendis Pharma Sustained Release Injectables Market Share (2018-2020)
Table Ascendis Pharma Main Business
Table Ascendis Pharma Recent Development
Table of Appendix